In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Bertil Lindahl
Speaker
Bertil Lindahl
Bertil Lindahl Bertil Lindahl

Uppsala University, Uppsala (Sweden)

Speciality : Acute Coronary Syndromes

Bertil Lindahl, MD, PhD is professor of Cardiology, Uppsala University and is the author of more than 240 peer reviewed original articles and more than 80 review articles, editorials and book chapters. His researched has focused on different aspects of acute coronary syndromes and especially on biochemical markers. He has performed observational studies as well as clinical trials and quality registry studies.

15 presentations from this speaker

Discussion - Cardiac biomarkers in the acute setting, from diagnosis to risk prediction.

Event : Acute Cardiovascular Care 2019

  • Session : Cardiac biomarkers in the acute setting, from diagnosis to risk prediction
  • Speaker : M Moeckel (Berlin,DE), B Lindahl (Uppsala,SE), R Twerenbold (Basel,CH), E Giannitsis (Heidelberg,DE), L Wallentin (Uppsala,SE)
  • Sponsored by Roche Diagnostics International Ltd.

Elevated troponin in a patient with dyspnoea and left ventricular systolic dysfunction - Conclusion and take home message.

Event : Acute Cardiovascular Care 2019

  • Session : Fourth universal definition of myocardial infarction: translating consensus to patient care
  • Speaker : B Lindahl (Uppsala,SE)

hs-troponin should be used in unselected patients with suspected ACS. PRO.

Event : Acute Cardiovascular Care 2019

  • Session : Controversies in diagnostic strategies for chest pain patients
  • Speaker : B Lindahl (Uppsala,SE)

Myocardial injury versus myocardial infarction - How to diagnose and how to manage

Event : ESC Congress 2019

  • Session : Expert Advice - Not all myocardial infarctions are created equal
  • Speaker : B Lindahl (Uppsala,SE)

Treatment of MINOCA patients.

Event : ESC Congress 2019

  • Session : Myocardial infarction and non-obstructive coronary arteries (MINOCA): what a headache!
  • Speaker : B Lindahl (Uppsala,SE)

Acute heart failure and troponin elevation - What do the guidelines say?

Event : ESC Congress 2018

  • Session : Myocardial injury versus myocardial infarction - Implications for clinical practice
  • Speaker : B Lindahl (Uppsala,SE)

Sensitivity matters! Why you need a high-sensitivity cardiac troponin assay.

Event : Acute Cardiovascular Care 2018

  • Session : Safe rule-out and rule-in of AMI
  • Speaker : B Lindahl (Uppsala,SE)

Cardiac troponin in patients with heart failure

Event : ESC Congress 2017

  • Session : Interpreting cardiac troponin
  • Speaker : B Lindahl (Uppsala,SE)

How to explain elevated troponin values in critical ill patients.

Event : Acute Cardiovascular Care 2016

  • Session : How to interpret troponin elevations beyond ACS
  • Speaker : B Lindahl (Uppsala,SE)

Incidence, treatment and prognosis of type 2 acute myocardial infarction in real life.

Event : Acute Cardiovascular Care 2016

  • Session : Type 2 versus type 1 myocardial infarction: why care?
  • Speaker : B Lindahl (Uppsala,SE)

Rule in and rule out strategies

Event : Acute Cardiovascular Care 2016

  • Session : Rule in and rule out strategies in the triage of chest pain
  • Speaker : B Lindahl (Uppsala,SE)
  • Joint session with the European Society for Emergency Medicine (EuSEM). This session is supported with an unrestricted educational grant by Thermo Fisher Scientific.

Gender: why is troponin different, and does it matter?

Event : Acute Cardiovascular Care 2015

  • Session : Friend or foe: troponin elevation
  • Speaker : B Lindahl (Uppsala,SE)

Type 2 myocardial infarction and non-ischaemic myocardial damage - possible and meaningful to separate? CONTRA.

Event : ESC Congress 2014

  • Session : Controversies in classification of myocardial infarction
  • Speaker : B Lindahl (Uppsala,SE)

Type 2 myocardial infarction and non-ischaemic myocardial damage - possible and meaningful to separate? REBUTTAL CONTRA.

Event : ESC Congress 2014

  • Session : Controversies in classification of myocardial infarction
  • Speaker : B Lindahl (Uppsala,SE)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are